185 related articles for article (PubMed ID: 34364885)
1. Tetraspanin TM4SF5 in hepatocytes negatively modulates SLC27A transporters during acute fatty acid supply.
Park D; Kim E; Lee H; Shin EA; Lee H; Lee JW
Arch Biochem Biophys; 2021 Oct; 710():109004. PubMed ID: 34364885
[TBL] [Abstract][Full Text] [Related]
2. Differential TM4SF5-mediated SIRT1 modulation and metabolic signaling in nonalcoholic steatohepatitis progression.
Ryu J; Kim E; Kang MK; Song DG; Shin EA; Lee H; Jung JW; Nam SH; Kim JE; Kim HJ; Son T; Kim S; Kim HY; Lee JW
J Pathol; 2021 Jan; 253(1):55-67. PubMed ID: 32918742
[TBL] [Abstract][Full Text] [Related]
3. Crosstalk between TM4SF5 and GLUT8 regulates fructose metabolism in hepatic steatosis.
Lee H; Kim E; Shin EA; Shon JC; Sun H; Kim JE; Jung JW; Lee H; Pinanga Y; Song DG; Liu KH; Lee JW
Mol Metab; 2022 Apr; 58():101451. PubMed ID: 35123128
[TBL] [Abstract][Full Text] [Related]
4. TM4SF5-dependent crosstalk between hepatocytes and macrophages to reprogram the inflammatory environment.
Kim E; Um H; Park J; Jung JW; Kim JE; Lee H; Shin EA; Pinanga Y; Lee H; Nam SH; Lee JW
Cell Rep; 2021 Nov; 37(7):110018. PubMed ID: 34788612
[TBL] [Abstract][Full Text] [Related]
5. TM4SF5-Mediated Regulation of Hepatocyte Transporters during Metabolic Liver Diseases.
Kim JE; Kim E; Lee JW
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955521
[TBL] [Abstract][Full Text] [Related]
6. Transmembrane 4 L Six Family Member 5 Senses Arginine for mTORC1 Signaling.
Jung JW; Macalino SJY; Cui M; Kim JE; Kim HJ; Song DG; Nam SH; Kim S; Choi S; Lee JW
Cell Metab; 2019 Jun; 29(6):1306-1319.e7. PubMed ID: 30956113
[TBL] [Abstract][Full Text] [Related]
7. Transmembrane 4 L six family member 5 (TM4SF5) enhances migration and invasion of hepatocytes for effective metastasis.
Lee SA; Kim TY; Kwak TK; Kim H; Kim S; Lee HJ; Kim SH; Park KH; Kim HJ; Cho M; Lee JW
J Cell Biochem; 2010 Sep; 111(1):59-66. PubMed ID: 20506553
[TBL] [Abstract][Full Text] [Related]
8. Growth arrest and DNA damage-inducible 45α protects against nonalcoholic steatohepatitis induced by methionine- and choline-deficient diet.
Tanaka N; Takahashi S; Hu X; Lu Y; Fujimori N; Golla S; Fang ZZ; Aoyama T; Krausz KW; Gonzalez FJ
Biochim Biophys Acta Mol Basis Dis; 2017 Dec; 1863(12):3170-3182. PubMed ID: 28844958
[TBL] [Abstract][Full Text] [Related]
9. Antagonistic regulation of transmembrane 4 L6 family member 5 attenuates fibrotic phenotypes in CCl(4) -treated mice.
Kang M; Jeong SJ; Park SY; Lee HJ; Kim HJ; Park KH; Ye SK; Kim SH; Lee JW
FEBS J; 2012 Feb; 279(4):625-35. PubMed ID: 22177033
[TBL] [Abstract][Full Text] [Related]
10. Dynamic and coordinated single-molecular interactions at TM4SF5-enriched microdomains guide invasive behaviors in 2- and 3-dimensional environments.
Kim HJ; Kwon S; Nam SH; Jung JW; Kang M; Ryu J; Kim JE; Cheong JG; Cho CY; Kim S; Song DG; Kim YN; Kim TY; Jung MK; Lee KM; Pack CG; Lee JW
FASEB J; 2017 Apr; 31(4):1461-1481. PubMed ID: 28073834
[TBL] [Abstract][Full Text] [Related]
11. Compounds that modulate AMPK activity and hepatic steatosis impact the biosynthesis of microRNAs required to maintain lipid homeostasis in hepatocytes.
Latorre J; Ortega FJ; Liñares-Pose L; Moreno-Navarrete JM; Lluch A; Comas F; Oliveras-Cañellas N; Ricart W; Höring M; Zhou Y; Liebisch G; Nidhina Haridas PA; Olkkonen VM; López M; Fernández-Real JM
EBioMedicine; 2020 Mar; 53():102697. PubMed ID: 32143184
[TBL] [Abstract][Full Text] [Related]
12. The extracellular loop 2 of TM4SF5 inhibits integrin alpha2 on hepatocytes under collagen type I environment.
Lee SA; Kim YM; Kwak TK; Kim HJ; Kim S; Ko W; Kim SH; Park KH; Kim HJ; Cho M; Lee JW
Carcinogenesis; 2009 Nov; 30(11):1872-9. PubMed ID: 19789264
[TBL] [Abstract][Full Text] [Related]
13. Correlations between transmembrane 4 L6 family member 5 (TM4SF5), CD151, and CD63 in liver fibrotic phenotypes and hepatic migration and invasive capacities.
Kang M; Ryu J; Lee D; Lee MS; Kim HJ; Nam SH; Song HE; Choi J; Lee GH; Kim TY; Lee H; Kim SJ; Ye SK; Kim S; Lee JW
PLoS One; 2014; 9(7):e102817. PubMed ID: 25033048
[TBL] [Abstract][Full Text] [Related]
14. Liver-originated small extracellular vesicles with TM4SF5 target brown adipose tissue for homeostatic glucose clearance.
Jung JW; Kim JE; Kim E; Lee H; Lee H; Shin EA; Lee JW
J Extracell Vesicles; 2022 Sep; 11(9):e12262. PubMed ID: 36063136
[TBL] [Abstract][Full Text] [Related]
15. Blockade of four-transmembrane L6 family member 5 (TM4SF5)-mediated tumorigenicity in hepatocytes by a synthetic chalcone derivative.
Lee SA; Ryu HW; Kim YM; Choi S; Lee MJ; Kwak TK; Kim HJ; Cho M; Park KH; Lee JW
Hepatology; 2009 Apr; 49(4):1316-25. PubMed ID: 19177595
[TBL] [Abstract][Full Text] [Related]
16. Plasma membrane phospholipase A2 controls hepatocellular fatty acid uptake and is responsive to pharmacological modulation: implications for nonalcoholic steatohepatitis.
Stremmel W; Staffer S; Wannhoff A; Pathil A; Chamulitrat W
FASEB J; 2014 Jul; 28(7):3159-70. PubMed ID: 24719358
[TBL] [Abstract][Full Text] [Related]
17. TM4SF5-Mediated Roles in the Development of Fibrotic Phenotypes.
Ryu J; Lee JW
Mediators Inflamm; 2017; 2017():5108525. PubMed ID: 28458469
[TBL] [Abstract][Full Text] [Related]
18. Increased hepatic Fatty Acid uptake and esterification contribute to tetracycline-induced steatosis in mice.
Choi YJ; Lee CH; Lee KY; Jung SH; Lee BH
Toxicol Sci; 2015 Jun; 145(2):273-82. PubMed ID: 25745068
[TBL] [Abstract][Full Text] [Related]
19. Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation.
Castaño D; Larequi E; Belza I; Astudillo AM; Martínez-Ansó E; Balsinde J; Argemi J; Aragon T; Moreno-Aliaga MJ; Muntane J; Prieto J; Bustos M
J Hepatol; 2014 May; 60(5):1017-25. PubMed ID: 24362075
[TBL] [Abstract][Full Text] [Related]
20. ILDR2 has a negligible role in hepatic steatosis.
Millings EJ; De Rosa MC; Fleet S; Watanabe K; Rausch R; Egli D; Li G; Leduc CA; Zhang Y; Fischer SG; Leibel RL
PLoS One; 2018; 13(5):e0197548. PubMed ID: 29847571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
